— Know what they know.
Not Investment Advice

HCANF OTC

Halo Collective Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -97.1% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $15081 mcap · 149M float · 0.0001% daily turnover

Income Trends

Revenue
$25M -32.2% ▼
Gross Profit
$5M +16.5% ▲
Operating Income
-$35M +16.3% ▲
Net Income
-$84M +11.4% ▲
EPS (Diluted)
$-10.55 +87.4% ▲
EBITDA
-$74M -95.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$11M$28M$22M$36M$25M
YoY Growth+0.0%+158.3%-23.1%+67.2%-32.2%
Cost of Revenue$11M$25M$17M$32M$19M
Gross Profit-$268K$3M$4M$4M$5M
Gross Margin-2.5%11.0%19.7%12.3%21.1%
R&D Expenses$0$0$0$0$0
SG&A Expenses$10M$26M$23M$43M$37M
Operating Expenses-$268K$3M$24M$45M$40M
Operating Income-$10M-$22M-$21M-$42M-$35M
Operating Margin-93.1%-76.6%-98.0%-115.3%-142.2%
Interest Expense$1M$2M$3M$4M$3M
Income Before Tax-$14M-$27M-$41M-$97M-$85M
Tax Expense-$89K$207K$6K$56K-$443K
Net Income-$14M-$28M-$41M-$95M-$84M
Net Margin-125.9%-98.1%-190.3%-261.5%-341.8%
EPS (Diluted)$-2200.00$-1400.00$-727.00$-83.62$-10.55
EBITDA-$12M-$25M-$38M-$38M-$74M
Shares Outstanding62503929831M1M8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms